ぶどう膜炎治療の世界市場レポート 2025年

ぶどう膜炎治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.8%で20億8,000万人に成長します。予測期間中の成長は、ヘルスケアサービスの低価格化、加齢に伴う眼障害の増加、高齢者人口の増加、研究イニシアチブの増加、一般市民の眼の健康に対する意識の高まりなどの要因によるものです。予測期間における主な動向としては、標的療法の開発、レーザー手術の進歩、革新的なドラッグデリバリーシステム、眼科診断ツールの改善、徐放性ドラッグデリバリーシステムの採用拡大などが挙げられます。

自己免疫疾患の有病率の増加は、ぶどう膜炎治療市場の拡大を促進すると予想されます。自己免疫疾患は、免疫系が身体の健康な細胞、組織、臓器を攻撃し、損傷させる疾患です。自己免疫疾患の増加は、免疫系に影響を与える遺伝的素因、環境的誘因、ライフスタイルの変化などの要因に影響されます。ぶどう膜炎治療は、炎症を抑え、免疫系の過活動をコントロールし、自己免疫関連の目の炎症に関連した視力低下を防ぐことで、これらの症状の管理に役立ちます。例えば、ドイツを拠点とするヘルスケアデータ分析会社Versorgungsatlas社の2022年の報告書によると、7,324万1,305人の被保険者のうち、630万4,340人が少なくとも1つの自己免疫疾患と診断され、有病率は8.61％でした。その結果、自己免疫疾患患者の増加がぶどう膜炎治療市場の成長に寄与しています。

ぶどう膜炎治療市場の主要企業は、患者の治療アドヒアランスを向上させるため、徐放性硝子体内インプラントなどの革新的なデバイスの開発に注力しています。このような長時間作用型のドラッグデリバリーシステムは、眼内に留置することで薬剤の放出を制御し、長時間持続させる。例えば、米国を拠点とするバイオ製薬会社アリメラ・サイエンシズは2022年2月、スペインで非感染性後部ぶどう膜炎（NIPU）の治療を目的とした徐放性硝子体内インプラントILUVIENを発売しました。このインプラントはフルオシノロンアセトニドを眼内に直接投与し、最長36ヶ月間ゆっくりと薬剤を放出します。この長期治療により、炎症を抑え、再発性NIPUの再発を予防することができます。ILUVIENは、この種の治療としては最初で唯一のものであり、注射の頻度を減らし患者の予後を改善しながら、より安定した効果を長期間持続させる。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ぶどう膜炎治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のぶどう膜炎治療市場：成長率分析
• 世界のぶどう膜炎治療市場の実績：規模と成長, 2019-2024
• 世界のぶどう膜炎治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界ぶどう膜炎治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のぶどう膜炎治療市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前部ぶどう膜炎
• 中間ぶどう膜炎
• 後部ぶどう膜炎
• ぶどう膜炎
• 世界のぶどう膜炎治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• トピック
• 全身的
• 注射剤
• 世界のぶどう膜炎治療市場原因別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染性
• 非感染性
• 世界のぶどう膜炎治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• 免疫抑制剤
• モノクローナル抗体
• 毛様体麻痺薬
• 抗生物質
• 抗ウイルス薬
• 抗真菌剤
• 鎮痛剤
• 世界のぶどう膜炎治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界のぶどう膜炎治療市場前部ぶどう膜炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染性前部ぶどう膜炎
• 非感染性前部ぶどう膜炎
• 世界のぶどう膜炎治療市場中間ぶどう膜炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染性中間ぶどう膜炎
• 非感染性中間ぶどう膜炎
• 世界のぶどう膜炎治療市場後部ぶどう膜炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染性後部ぶどう膜炎
• 非感染性後部ぶどう膜炎
• 世界のぶどう膜炎治療市場、全ぶどう膜炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染性全ぶどう膜炎
• 非感染性汎ぶどう膜炎

第7章 地域別・国別分析

• 世界のぶどう膜炎治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のぶどう膜炎治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ぶどう膜炎治療市場：競合情勢
• ぶどう膜炎治療市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Kubota Vision Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• UCB S.A.
• Sun Pharmaceutical Industries Ltd.
• Bausch & Lomb Incorporated
• Horizon Therapeutics plc
• Cipla Ltd.
• Santen Pharmaceutical Co. Ltd.
• Galapagos NV
• ANI Pharmaceuticals Inc.
• EyePoint Pharmaceuticals Inc.
• Entod Pharmaceuticals Ltd.
• Sirion Therapeutics Inc.
• Kiora Pharmaceuticals Inc.
• Lux Biosciences Inc.
• Inflammasome Therapeutics Inc.
• Clearside Biomedical Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ぶどう膜炎治療市場2029：新たな機会を提供する国
• ぶどう膜炎治療市場2029：新たな機会を提供するセグメント
• ぶどう膜炎治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Uveitis treatment involves medical measures designed to reduce inflammation inside the eye, helping to relieve symptoms and prevent vision loss. The treatment approach depends on the underlying cause and may include corticosteroids, immunosuppressive drugs, or antimicrobial medications. These treatments can be administered in various forms, such as eye drops, oral medications, injections, or implants, depending on the type and severity of the uveitis.

The primary indications for uveitis treatment include anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis. Anterior uveitis refers to inflammation of the front part of the uvea, primarily affecting the iris and ciliary body, often resulting in eye pain, redness, and vision changes. Treatment for uveitis can be categorized by the method of administration such as topical, systemic, or injectable therapies. These treatments address either infectious or non-infectious causes. Available therapeutic options include corticosteroids, immunosuppressants, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungals, and analgesics. These treatments are available through various distribution channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others.

The uveitis treatment market research report is one of a series of new reports from The Business Research Company that provides uveitis treatment market statistics, including the uveitis treatment industry global market size, regional shares, competitors with the uveitis treatment market share, detailed uveitis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the uveitis treatment industry. This uveitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The uveitis treatment market size has grown strongly in recent years. It will grow from $1.43 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period can be attributed to several factors, including the increased prevalence of autoimmune conditions, a growing geriatric population, a higher incidence of uveitis, enhanced awareness among healthcare professionals about the importance of early diagnosis and treatment, and a rising occurrence of infectious diseases.

The uveitis treatment market size is expected to see strong growth in the next few years. It will grow to 2.08 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth during the forecast period can be attributed to factors such as the increasing affordability of healthcare services, a rise in age-related eye disorders, a growing senior population, more research initiatives, and heightened awareness of eye health among the public. Key trends in the forecast period include the development of targeted therapies, advancements in laser surgery, innovative drug delivery systems, improvements in ophthalmology diagnostic tools, and a growing adoption of sustained-release drug delivery systems.

The growing prevalence of autoimmune conditions is expected to drive the expansion of the uveitis treatment market. Autoimmune conditions involve diseases in which the immune system attacks and damages the body's healthy cells, tissues, or organs. The rise in autoimmune diseases is influenced by factors such as genetic predisposition, environmental triggers, and lifestyle changes that affect the immune system. Uveitis treatment helps manage these conditions by reducing inflammation, controlling the immune system's overactivity, and preventing vision loss linked to autoimmune-related eye inflammation. For example, a 2022 report by the Germany-based healthcare data analytics company Versorgungsatlas revealed that, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, leading to a prevalence rate of 8.61%. As a result, the increasing number of autoimmune cases is contributing to the growth of the uveitis treatment market.

Leading companies in the uveitis treatment market are focusing on creating innovative devices such as sustained-release intravitreal implants to improve patient adherence to treatment. These long-acting drug delivery systems are placed in the eye to ensure controlled and prolonged medication release. For instance, in February 2022, Alimera Sciences, a US-based biopharmaceutical company, launched ILUVIEN, a sustained-release intravitreal implant aimed at treating non-infectious posterior uveitis (NIPU) in Spain. The implant delivers fluocinolone acetonide directly into the eye, releasing the drug slowly for up to 36 months. This long-term treatment helps reduce inflammation and prevent relapses in recurrent NIPU. ILUVIEN is the first and only treatment of its kind for this condition, offering a more consistent and long-lasting effect while reducing the frequency of injections and improving patient outcomes.

In September 2024, ANI Pharmaceuticals, a US-based pharmaceutical company, acquired Alimera Sciences for an undisclosed sum. This acquisition aims to enhance ANI's Rare Disease division and broaden its presence in the ophthalmology market. Alimera Sciences specializes in the development and commercialization of ophthalmic pharmaceuticals, particularly those focused on retinal diseases such as uveitis.

Major players in the uveitis treatment market are Merck & Co. Inc., AbbVie Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Kubota Vision Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Horizon Therapeutics plc, Cipla Ltd., Santen Pharmaceutical Co. Ltd., Galapagos NV, ANI Pharmaceuticals Inc., EyePoint Pharmaceuticals Inc., Entod Pharmaceuticals Ltd., Sirion Therapeutics Inc., Kiora Pharmaceuticals Inc., Lux Biosciences Inc., Inflammasome Therapeutics Inc., and Clearside Biomedical Inc.

North America was the largest region in the uveitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in uveitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the uveitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The uveitis treatment market consists of sales of drugs, diagnostic tools, surgical equipment, intravitreal implants, and injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uveitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on uveitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for uveitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The uveitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Indication: Anterior Uveitis; Intermediate Uveitis; Posterior Uveitis; Panuveitis
• 2) By Route Of Administration: Topical; Systemic; Injectable
• 3) By Cause: Infectious; Non-infectious
• 4) By Treatment: Corticosteroids; Immunosuppressant; Monoclonal Antibodies; Cycloplegic Agents; Antibiotics; Antivirals; Antifungal; Analgesics
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Subsegments:
• 1) By Anterior Uveitis: Infectious Anterior Uveitis; Non-Infectious Anterior Uveitis
• 2) By Intermediate Uveitis: Infectious Intermediate Uveitis; Non-Infectious Intermediate Uveitis
• 3) By Posterior Uveitis: Infectious Posterior Uveitis; Non-Infectious Posterior Uveitis
• 4) By Panuveitis: Infectious Panuveitis; Non-Infectious Panuveitis
• Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Regeneron Pharmaceuticals Inc.; Kubota Vision Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Uveitis Treatment Market Characteristics

3. Uveitis Treatment Market Trends And Strategies

4. Uveitis Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Uveitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Uveitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Uveitis Treatment Market Growth Rate Analysis
• 5.4. Global Uveitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Uveitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Uveitis Treatment Total Addressable Market (TAM)

6. Uveitis Treatment Market Segmentation

• 6.1. Global Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anterior Uveitis
• Intermediate Uveitis
• Posterior Uveitis
• Panuveitis
• 6.2. Global Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Systemic
• Injectable
• 6.3. Global Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious
• Non-infectious
• 6.4. Global Uveitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Immunosuppressant
• Monoclonal Antibodies
• Cycloplegic Agents
• Antibiotics
• Antivirals
• Antifungal
• Analgesics
• 6.5. Global Uveitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.6. Global Uveitis Treatment Market, Sub-Segmentation Of Anterior Uveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Anterior Uveitis
• Non-Infectious Anterior Uveitis
• 6.7. Global Uveitis Treatment Market, Sub-Segmentation Of Intermediate Uveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Intermediate Uveitis
• Non-Infectious Intermediate Uveitis
• 6.8. Global Uveitis Treatment Market, Sub-Segmentation Of Posterior Uveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Posterior Uveitis
• Non-Infectious Posterior Uveitis
• 6.9. Global Uveitis Treatment Market, Sub-Segmentation Of Panuveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Panuveitis
• Non-Infectious Panuveitis

7. Uveitis Treatment Market Regional And Country Analysis

• 7.1. Global Uveitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Uveitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Uveitis Treatment Market

• 8.1. Asia-Pacific Uveitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Uveitis Treatment Market

• 9.1. China Uveitis Treatment Market Overview
• 9.2. China Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Uveitis Treatment Market

• 10.1. India Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Uveitis Treatment Market

• 11.1. Japan Uveitis Treatment Market Overview
• 11.2. Japan Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Uveitis Treatment Market

• 12.1. Australia Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Uveitis Treatment Market

• 13.1. Indonesia Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Uveitis Treatment Market

• 14.1. South Korea Uveitis Treatment Market Overview
• 14.2. South Korea Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Uveitis Treatment Market

• 15.1. Western Europe Uveitis Treatment Market Overview
• 15.2. Western Europe Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Uveitis Treatment Market

• 16.1. UK Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Uveitis Treatment Market

• 17.1. Germany Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Uveitis Treatment Market

• 18.1. France Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Uveitis Treatment Market

• 19.1. Italy Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Uveitis Treatment Market

• 20.1. Spain Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Uveitis Treatment Market

• 21.1. Eastern Europe Uveitis Treatment Market Overview
• 21.2. Eastern Europe Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Uveitis Treatment Market

• 22.1. Russia Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Uveitis Treatment Market

• 23.1. North America Uveitis Treatment Market Overview
• 23.2. North America Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Uveitis Treatment Market

• 24.1. USA Uveitis Treatment Market Overview
• 24.2. USA Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Uveitis Treatment Market

• 25.1. Canada Uveitis Treatment Market Overview
• 25.2. Canada Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Uveitis Treatment Market

• 26.1. South America Uveitis Treatment Market Overview
• 26.2. South America Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Uveitis Treatment Market

• 27.1. Brazil Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Uveitis Treatment Market

• 28.1. Middle East Uveitis Treatment Market Overview
• 28.2. Middle East Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Uveitis Treatment Market

• 29.1. Africa Uveitis Treatment Market Overview
• 29.2. Africa Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Uveitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Uveitis Treatment Market Competitive Landscape
• 30.2. Uveitis Treatment Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Kubota Vision Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Uveitis Treatment Market Other Major And Innovative Companies

• 31.1. UCB S.A.
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Bausch & Lomb Incorporated
• 31.4. Horizon Therapeutics plc
• 31.5. Cipla Ltd.
• 31.6. Santen Pharmaceutical Co. Ltd.
• 31.7. Galapagos NV
• 31.8. ANI Pharmaceuticals Inc.
• 31.9. EyePoint Pharmaceuticals Inc.
• 31.10. Entod Pharmaceuticals Ltd.
• 31.11. Sirion Therapeutics Inc.
• 31.12. Kiora Pharmaceuticals Inc.
• 31.13. Lux Biosciences Inc.
• 31.14. Inflammasome Therapeutics Inc.
• 31.15. Clearside Biomedical Inc.

32. Global Uveitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Uveitis Treatment Market

34. Recent Developments In The Uveitis Treatment Market

35. Uveitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Uveitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Uveitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Uveitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer